UBS Maintains Buy on Eastman Chemical, Raises Price Target to $92

Benzinga Newsdesk www.benzinga.com Positive 83.3%

Neg 0% Neu 0% Pos 83.3%

UBS analyst Joshua Spector maintains Eastman Chemical (NYSE:EMN) with a Buy and raises the price target from $89 to $92.